Publications
5674 Results
- Journal / Conference
- ASCO, #C-900
- Year
- 1983
- Research Committee(s)
- Brain
- Study Number(s)
- SWOG-7812
Anguidine (Diacetoxyscerpenol) in central nervous system tumors. A Southwest Oncology Group study.
- Journal / Conference
- Investigational New Drugs 1: 315-319
- Year
- 1983
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-7726
Phase II evaluation of rubidazone (NSC-164011) in advanced carcinoma of the breast A Southwest Oncology Group study
- Journal / Conference
- Cancer Treat Rep 67:697-700
- Year
- 1983
- Research Committee(s)
- Multiple sites
- Study Number(s)
- SWOG-7963
Phase II evaluation of Amsacrine (m-AMSA) in solid tumors, myeloma, and lymphoma: A University of Arizona and Southwest Oncology Group study
- Journal / Conference
- Investigational New Drugs 1:181-184
- Year
- 1983
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8008
Mitoxantrone in advanced breast cancer: A Phase II trial of the Southwest Oncology Group
- Journal / Conference
- ASCO #C-390
- Year
- 1983
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-7436
Adjuvant chemotherapy for operable breast cancer with positive axillary nodes
- Journal / Conference
- ASCO #C-383
- Year
- 1983
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-7827
Adjuvant chemotherapy and hormonal therapy for operable breast cancer with positive axillary nodes
- Journal / Conference
- Breast Cancer Res Treat 3:306
- Year
- 1983
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-7827
Adjuvant chemohormonal therapy for operable breast cancer: A SWOG study
- Journal / Conference
- AACR #563
- Year
- 1983
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8076
Aggressive chemotherapy for estrogen receptor (ER) negative metastatic breast cancer (MBC) For the Southwest Oncology Group
- Journal / Conference
- Cancer Treat Rep 67:77-79
- Year
- 1983
- Study Number(s)
- SWOG-7717